
News|Articles|March 2, 2005
- Pharmaceutical Technology-03-02-2005
- Volume 29
- Issue 3
A “Disclosure Defense” in Liability Law
In this time of liability reform, pharma deserves the chance to align its economic interests with its ethical obligations to the patient.
Advertisement
Articles in this issue
almost 21 years ago
March 2005almost 21 years ago
Packaging Becomes Part of the Prescriptionalmost 21 years ago
Appraisal of the Laser Diffraction Particle-Sizing Techniquealmost 21 years ago
Optimism Taking Over in Pharmaceutical Chemicalsalmost 21 years ago
In the Spotlight - March 2005almost 21 years ago
Managing Aseptic Interventionsalmost 21 years ago
Validating Automated Systemsalmost 21 years ago
Combination Products Raise Manufacturing ChallengesNewsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Batch Certification for New Manufacturing Technologies: The Qualified Person Role in a Digital Environment
2
FDA Deploys Agentic AI Capabilities for Agency Staff
3
Lilly Launches UK Trial of Weight-Loss Drug as US Price Drops
4
BirchBioMed’s Idiopathic Pulmonary Fibrosis Treatment Receives Orphan Drug Designation
5





